Eukaryotic translation initiation factor 4A1 (eIF4A1) is an ATP-dependent RNA helicase that participates in a variety of biological and pathological processes such as cell proliferation and apoptosis, and cancer. In this study we investigated the role of eIF4A1 in ischemic heart disease. The myocardial ischemia/reperfusion (I/R) model was established in mice by ligation of the left anterior descending artery for 45âmin with the subsequent reperfusion for 24âh; cultured neonatal mouse ventricular cardiomyocytes (NMVCs) treated with H(2)O(2) (200âμM) or H/R (12âh hypoxia and 12âh reoxygenation) were used for in vitro study. We showed that the expression levels of eIF4A1 were significantly increased in I/R-treated myocardium and in H(2)O(2)- or H/R-treated NMVCs. In NMVCs, eIF4A1 overexpression drastically enhanced LDH level, caspase 3 activity, and cell apoptosis. eIF4A1 overexpression also significantly reduced anti-apoptotic protein Bcl2 and elevated pro-apoptotic protein Bax expression, whereas eIF4A1 deficiency produced the opposite responses. Importantly, cardiomyocyte-specific eIF4A1 knockout attenuated cardiomyocyte apoptosis, reduced infarct area, and improved cardiac function in myocardial I/R mice. We demonstrated that eIF4A1 directly bound to transgelin (Tagln) to prevent its ubiquitination degradation and subsequent up-regulation of p53, and then promoted nuclear translocation of Tagln and p53. Nuclear localization of Tagln and p53 was increased in H(2)O(2)-treated NMVCs. Silencing Tagln reversed the pro-apoptotic effects of eIF4A1. Noticeably, eIF4A1 exerted the similar effects in AC16 human cardiomyocytes. In conclusion, eIF4A1 is a detrimental factor in myocardial I/R injury via promoting expression and nuclear translocation of Tagln and p53 and might be a potential target for myocardial I/R injury. This study highlights a novel biological role of eIF4A1 by interacting with non-translational-related factor Tagln in myocardial I/R injury.
eIF4A1 exacerbates myocardial ischemia-reperfusion injury in mice by promoting nuclear translocation of transgelin/p53.
eIF4A1 通过促进 transgelin/p53 的核转位加剧小鼠心肌缺血再灌注损伤
阅读:7
作者:Li Dan-Yang, Hu Xiao-Xi, Tian Zhong-Rui, Ning Qi-Wen, Liu Jiang-Qi, Yue Ying, Yuan Wei, Meng Bo, Li Jia-Liang, Zhang Yang, Pan Zhen-Wei, Zhuang Yu-Ting, Lu Yan-Jie
| 期刊: | Acta Pharmacologica Sinica | 影响因子: | 8.400 |
| 时间: | 2025 | 起止号: | 2025 May;46(5):1236-1249 |
| doi: | 10.1038/s41401-024-01467-6 | 靶点: | P53 |
| 研究方向: | 炎症/感染 | 疾病类型: | 心肌炎 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
